Array Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-05-12　·　153 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 11.4 Bn
2033 年預估規模: USD 31.1 Bn
年複合成長率 CAGR: 15.4%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-05-12頁數 153報告編號 CMI4221

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Array Market (Life Science and Biotechnology Instruments), By Type (DNA Array, Protein Array, Tissue Array, Cell Array, Others (Peptide Array and Others)), By End User (Biopharmaceutical and Pharmaceutical Companies, Diagnostic Laboratories, Research Laboratories, Others (Academic Institutes and among Others)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields. A microarray or biochip is a lab-oriented microscope slide that is usually made of glass, a silicon chip, or a nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. Market Dynamics Microarrays leverage biological information with bioinformatics knowledge to bring new insights to many biological systems and have been applied most intensively to the field of cancer research. A microarray, therefore, measures the levels of mRNA transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to foster market growth over the forecast period. For instance, In February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers. Furthermore, According to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020 Key features of the study • This report provides an in-depth analysis of the global array market (life science and biotechnology instruments) and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global array market (life science and biotechnology instruments) based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Illumina, Inc., Roche Diagnostics Nederland B.V., Bio-Rad Laboratories, Inc., Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • Global array market (life science and biotechnology instruments)report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global array market (life science and biotechnology instruments) Market Segmentation • By Type (Revenue, USD Bn, 2021-2033) o DNA Array o Protein Array o Tissue Array o Cell Array o Others (Peptide Array and Others) • By End user (Revenue, USD Bn, 2021-2033) o Biopharmaceutical and Pharmaceutical Companies o Diagnostic Laboratories o Research Laboratories o Others (Academic Institutes and among Others) • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Thermo Fisher Scientific Inc. o Illumina, Inc. o Roche Diagnostics Nederland B.V. o Bio-Rad Laboratories, Inc. o Life Technologies o Caliper Life Sciences o Perkin Elmer, Inc. o Siemens Healthineers o Agilent Technologies Inc. o PathogenDx, Inc. o Twist Bioscience Corporation o Arraylt Corporation o Molecular Device, LLC o Raybiotech Inc.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Global Array Market (Life Science and Biotechnology Instruments), By Type  Global Array Market (Life Science and Biotechnology Instruments), By End User 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trend 4. Global Array Market (Life Science and Biotechnology Instruments), By Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o DNA Array  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Protein Array  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Tissue Array  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cell Array  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others (Peptide Array and Others)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Array Market (Life Science and Biotechnology Instruments), By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Biopharmaceutical and Pharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Research Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others (Academic Institutes and among Others)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Array Market (Life Science and Biotechnology Instruments), By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 7. Competitive Landscape o Thermo Fisher Scientific Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Illumina, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Roche Diagnostics Nederland B.V.,  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bio-Rad Laboratories, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Life Technologies  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Caliper Life Sciences  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Perkin Elmer, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Siemens Healthineers  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Agilent Technologies Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o PathogenDx, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Twist Bioscience Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Arraylt Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Molecular Device, LLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Raybiotech Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 8. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 9. References and Research Methodology o References o Research Methodology o About us

提及公司

Thermo Fisher Scientific Inc.Illumina, Inc.Roche Diagnostics Nederland B.V.Bio-Rad Laboratories, Inc.Life TechnologiesCaliper Life SciencesPerkin Elmer, Inc.Siemens HealthineersAgilent Technologies Inc.PathogenDx, Inc.Twist Bioscience CorporationArraylt CorporationMolecular Device, LLCRaybiotech Inc.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們